KCNJ15 | Potassium inwardly-rectifying channel, subfamily J, member 15 | Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNQ1 | Potassium voltage-gated channel, KQT-like subfamily, member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNQ5 | Potassium voltage-gated channel, KQT-like subfamily, member 5 | Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCTD8 | Potassium channel tetramerization domain containing 8 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
KHDRBS2 | KH domain containing, RNA binding, signal transduction associated 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
KLHL14 | Kelch-like family member 14 | Predicted intracellular proteins
| | | | | Tissue enhanced |
KLRG2 | Killer cell lectin-like receptor subfamily G, member 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
KRT7 | Keratin 7 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
LCN12 | Lipocalin 12 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LPCAT2 | Lysophosphatidylcholine acyltransferase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
LRAT | Lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LURAP1 | Leucine rich adaptor protein 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
MARVELD2 | MARVEL domain containing 2 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MEI4 | Meiosis-specific 4 homolog (S. cerevisiae) | Predicted secreted proteins
| | | | | Tissue enhanced |
MGAT4C | MGAT4 family, member C | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
MPPED2 | Metallophosphoesterase domain containing 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
MT1G | Metallothionein 1G | Cancer-related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MUC15 | Mucin 15, cell surface associated | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NPM2 | Nucleophosmin/nucleoplasmin 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
NPNT | Nephronectin | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NTRK2 | Neurotrophic tyrosine kinase, receptor, type 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
NUPR1 | Nuclear protein, transcriptional regulator, 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
OCA2 | Oculocutaneous albinism II | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
OCLN | Occludin | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
OR2A1 | Olfactory receptor, family 2, subfamily A, member 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
OR2A42 | Olfactory receptor, family 2, subfamily A, member 42 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
OR2T33 | Olfactory receptor, family 2, subfamily T, member 33 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
OR2T8 | Olfactory receptor, family 2, subfamily T, member 8 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
OR2W3 | Olfactory receptor, family 2, subfamily W, member 3 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PBX4 | Pre-B-cell leukemia homeobox 4 | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
PDE10A | Phosphodiesterase 10A | Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
PDE1A | Phosphodiesterase 1A, calmodulin-dependent | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
PGF | Placental growth factor | Cancer-related genes Candidate cardiovascular disease genes FDA approved drug targets Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PLA2R1 | Phospholipase A2 receptor 1, 180kDa | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PLCB4 | Phospholipase C, beta 4 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
PLEKHD1 | Pleckstrin homology domain containing, family D (with coiled-coil domains) member 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PLEKHG4B | Pleckstrin homology domain containing, family G (with RhoGef domain) member 4B | Predicted intracellular proteins
| | | | | Tissue enhanced |
PLEKHH1 | Pleckstrin homology domain containing, family H (with MyTH4 domain) member 1 | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
PPP1R14C | Protein phosphatase 1, regulatory (inhibitor) subunit 14C | Predicted intracellular proteins
| | | | | Tissue enhanced |
PQLC2L | PQ loop repeat containing 2-like | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PRKX | Protein kinase, X-linked | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PRTG | Protogenin | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RAB43 | RAB43, member RAS oncogene family | Predicted intracellular proteins
| | | | | Tissue enhanced |
RAG1 | Recombination activating gene 1 | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
RAP1GAP | RAP1 GTPase activating protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
RGL3 | Ral guanine nucleotide dissociation stimulator-like 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
RNF165 | Ring finger protein 165 | Predicted intracellular proteins
| | | | | Tissue enhanced |
RPS6KA6 | Ribosomal protein S6 kinase, 90kDa, polypeptide 6 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
S100A5 | S100 calcium binding protein A5 | Predicted intracellular proteins
| | | | | Tissue enhanced |
SALL1 | Spalt-like transcription factor 1 | Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |